Warning letter
Highland Laboratories, Inc.: warning letter of Oct 4, 2005
FDA warning letter UCM075593 · Seattle District Office
Key facts
| Reference number | UCM075593 |
|---|---|
| Company | Highland Laboratories, Inc. |
| Subject | Lacks Approved New Drug Application |
| Issue date | Oct 4, 2005 |
| Posted date | Oct 4, 2005 |
| Issuing office | Seattle District Office |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Mount Angel |
| Inspection ZIP | 97362-8910 |
| Inspection start date | Jun 29, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: